Zoetis Acquires Platinum Performance

Platinum Equity Acquires Petmate

September 15, 2021

Consumer Products

Platinum Equity has acquired Petmate, a longtime Arlington, Texas-based manufacturer and marketer of pet products, from Olympus Partners. Platinum Equity plans to support Petmate's organic growth and pursue additional M&A to broaden the company's product portfolio and accelerate expansion in e-commerce and retail channels; financial terms were not disclosed.

Zoetis Acquires Phoenix Central Laboratory (Phoenix Lab)

October 31, 2019

Veterinary

Zoetis has completed the acquisition of Phoenix Central Laboratory for Veterinarians, Inc. (Phoenix Lab), a Mukilteo, Washington-based veterinary reference laboratory. The purchase expands Zoetis's diagnostics capabilities by adding reference laboratory services to its existing point-of-care diagnostic portfolio; financial terms were not disclosed.

Zoetis Completes Acquisition of Jurox

September 30, 2022

Pharmaceuticals

Zoetis Inc. has completed its acquisition of Jurox, a privately held Australian animal health company that develops, manufactures and markets veterinary medicines, including the anaesthetic Alfaxan. The deal expands Zoetis' veterinary product portfolio and manufacturing capabilities in Australia and supports greater global distribution of Jurox products.

Phibro Acquires Zoetis' Medicated Feed Additive Business

November 1, 2024

Veterinary

Phibro Animal Health Corp. has completed the acquisition of Zoetis Inc.'s medicated feed additive product portfolio and certain water‑soluble products. The deal transfers more than 37 product lines, six manufacturing sites (U.S., Italy, China) and a team of over 300 employees to Phibro, expanding its species coverage and product capabilities across cattle, swine and poultry.

Zoetis to Acquire Neogen’s Animal Genomics Business for $160 Million

March 3, 2026

Healthcare Services

Zoetis announced it has entered into a definitive agreement to acquire Neogen Corporation’s animal genomics business for $160 million, subject to customary closing adjustments. The deal is intended to strengthen Zoetis’ leadership in Precision Animal Health by integrating Neogen’s genomic technologies and data solutions to expand predictive insights and individualized care.

Veterinary Pharmaceutical Solutions Acquires Diamond Animal Health

January 18, 2024

Veterinary

Veterinary Pharmaceutical Solutions (VPS), a Granite Creek Capital Partners portfolio company, acquired Diamond Animal Health from Mars Corporation. Granite Creek supported the deal with a follow-on investment from its FlexCap II fund, creating an integrated animal health platform combining VPS's compounding capabilities with Diamond's contract manufacturing and vaccine production.